Residual Stroke Risk in Patients with Atrial Fibrillation Treated with Non-Vitamin K Oral Anticoagulants: An 8-Year Retrospective Cohort Study

BACKGROUND: Use of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in non-valvular atrial fibrillation (NVAF) is common and significantly reduces stroke occurrence. Yet little is known about patients who have a stroke despite treatment. OBJECTIVE: The aim of this work was...

Descripción completa

Detalles Bibliográficos
Autores principales: Szeto, Cheuk Ling Charing, Hui, Kwok Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879322/
https://www.ncbi.nlm.nih.gov/pubmed/33461208
http://dx.doi.org/10.1159/000513105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879322/
https://www.ncbi.nlm.nih.gov/pubmed/33461208
http://dx.doi.org/10.1159/000513105

Ejemplares similares